GLORIA PHARMA.(SZ:002437) Xin Lang Cai Jing·2025-10-13 08:44Core Viewpoint - In 2025, Harbin Yuheng Pharmaceutical Co., Ltd. approved a proposal to provide guarantees for comprehensive bank credit applications by its wholly-owned subsidiaries, indicating a strategic move to support its subsidiaries' financial needs [1] Group 1: Company Financials - As of June 30, 2025, Yudong Pharmaceutical has total assets of 354.27 million yuan and net assets of 306.26 million yuan [1] - Laibotong has total assets of 102.24 million yuan and net assets of 39.93 million yuan [1] Group 2: Guarantee Details - The company provided a joint liability guarantee for Yudong Pharmaceutical's 30 million yuan credit from China Merchants Bank Guangzhou Branch and Laibotong's 10 million yuan credit from Shanghai Pudong Development Bank Harbin Branch [1] - After this guarantee, the total amount guaranteed by the company for its controlling and wholly-owned subsidiaries reached 40 million yuan, accounting for 2.06% of the audited net assets attributable to shareholders of the listed company for 2024 [1] - There are no overdue or other guarantee risks associated with this arrangement [1]